RxDoctor Payments Data

Kevin Peng, MD

Otology & Neurotology · Los Angeles, CANPI 1245556653

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,550 of the $16,937 with a category attached, or 68.2%. Medtronic accounts for 81.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $11,696 and has fallen 69.7% since, to $3,548 in 2025.

$16,937in general payments, 2019–2025

Across 55 payments — averaging $307.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$14K
  • Cochlear Americas$1K
  • Med-el Corporation$893
  • Acclarent, Inc$394
  • Integra Lifesciences Corporation$216
  • Axogen$134
  • plus $453 from 5 others

What the payments were for

  • Consulting fees$11,55068%
  • Travel & lodging$2,72016%
  • Food & beverage$2,66816%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,937 in reported general payments places this provider in the 80th percentile of 43 otology & neurotology providers in California.

See all otology & neurotology providers in California

Medicare billing

Part B allowed, 2024
$300,280
Medicare patients
554
Services billed
5,580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth83$9,938
Clobetasol Propionate42$1,234
Potassium Chloride24$433
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid58$359
Nortriptyline Hcl38$206
Fluticasone Propionate21$165
Venlafaxine Hcl ErVenlafaxine Hcl17$108
Methylprednisolone18$98
Prednisone23$85
Montelukast Sodium13$61
Meclizine Hcl11$56
Hydrochlorothiazide23$55

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →